|
Wisconsin COVID-19 Vaccine Program |
|
This email is being sent to local health officers, tribal health directors, COVID-19 vaccinators, COVID-19 vaccine stakeholders, HERC coordinators, and key DHS staff.
Reflection
As of May 26, 2022, Wisconsin has administered more than 9.5 million doses of COVID-19 vaccine, including more than 2 million additional or booster doses.
-
64.4% of all Wisconsin residents have received at least one dose.
-
61.2% of all Wisconsin residents have completed the vaccine series.
-
34.5% of all Wisconsin residents have received an additional/booster dose.
Thank you, Wisconsin vaccinators, for your continued hard work and dedication.
COVID-19 Vaccine Distribution Planning Survey: Children under 5 Years
Pending approval by the FDA, we anticipate that beginning in June vaccinators will be able to place orders for new COVID-19 vaccine products for children 6 months through 4 years of age as they undergo review and potential approval for use.
This survey is intended to:
-
Measure and map intent to vaccinate this new age group
-
Inform the DHS vaccine distribution plan, and
-
Proactively identify any potential gaps in access to these new vaccine products
Please complete and submit one survey per vaccination site by June 1.
DHS Supports CDC Recommendation for Pfizer COVID-19 Vaccine Booster Dose for Children Ages 5 through 11 years
The Wisconsin Department of Health Services (DHS) supports the Centers for Disease Control and Prevention's (CDC) recommendation that children ages 5 through 11 years should receive a booster dose 5 months after their initial Pfizer-BioNTech (Pfizer) COVID-19 vaccination series. On May 19, after rigorous review of all available data, the Advisory Committee on Immunization Practices (ACIP) recommended, and the CDC director endorsed this recommendation.
On the same day, the CDC also strengthened another booster recommendation by updating a “may” receive to a “should” receive for the following people regarding receiving a second COVID-19 booster dose. People ages 12 years and older who are moderately or severely immunocompromised, and all people ages 50 years and older should receive a second COVID-19 booster dose.
Read the full bulletin sent on Monday, May 24 here.
Changes to VRBPAC Dates to Discuss Pediatric Vaccines
-
June 14: FDA and experts will discuss the Moderna EUA request for COVID-19 vaccines for people 6 years through 17 years of age.
-
June 15: Discussion about the Moderna EUA request for COVID-19 vaccines for children 6 months through 5 years of age and Pfizer BioNTech EUA request for COVID-19 vaccine for children 6 months through 4 years of age, based on completion of an EUA submission.
Additional meetings scheduled:
-
June 7: VRBPAC will meet to discuss an Emergency Use Authorization (EUA) request for a COVID-19 vaccine manufactured by Novavax to prevent COVID-19 in individuals 18 years of age and older.
-
June 28: VRBPAC will meet to discuss whether the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified, and if so, which strain(s) should be selected for Fall 2022. This meeting is a follow-up to the April 6th VRBPAC meeting where general considerations for future COVID-19 vaccine booster doses and the strain composition of COVID-19 vaccines to further meet public health needs were discussed.
Start Planning Now for Summer Mobile COVID-19 Vaccination Clinics
DHS’ vaccination partner AMI Expeditionary Healthcare (AMI) conducts free COVID-19 mobile vaccination clinics. These clinics are a great fit for summer events, festivals, large gatherings, and sites/locations that are heavily visited when the weather gets warmer, and school is out.
The convenience of an on-site clinic can make it possible for many people who otherwise may not have received the COVID-19 vaccine to get vaccinated or boosted, which will help keep families and communities safe.
To request an AMI mobile vaccination clinic, simply fill out the State COVID-19 Resource Matching Survey. DHS can accommodate requests up to 4-weeks in advance so start planning now for those high-traffic events in your county or area.
New and Updated Resources
Updated Clinical Guidance from CDC
-
MMWR Early Release: Post–COVID-19 Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021
Updated Communication and Education Resources from CDC
Updated Communication and Education Resources from DHS
In Case You Missed It
Wisconsin COVID-19 Vaccine Program Webinar Schedule
Bi-weekly COVID-19 Vaccine Program updates are held every other Tuesday from 11 a.m.-12 p.m.
Note: There will be no webinar on May 31 due to the Memorial Day holiday. The next webinar will be held on Tuesday, June 14.
Register for the meeting series here. Watch recordings of past webinars here.
Memorial Day Holiday Delivery Reminders
-
No vaccine deliveries will occur on Monday, May 30 (Memorial Day).
Moderna and Johnson & Johnson Centrally Distributed Vaccines
-
No vaccine deliveries will occur on Monday, May 30, or Tuesday, May 31 (you may receive ancillary kits on Tuesday for orders arriving on June 1).
Vaccine Inventory Update and Reminders
Cartons and vials of Pfizer-BioNTech Purple Cap COVID-19 vaccine with labeled expiration dates of October 2021 through November 2022 may now be used beyond the printed date. The new updated expiry dates can be found here. These vaccines may remain in use until the updated expiration date as long as approved storage conditions between -90ºC to -60ºC (-130ºF to -76ºF) have been maintained.
Please continue to use Pfizer Purple Cap before ordering the Pfizer Gray Cap. Please keep your inventory of the Purple and Gray cap vials separate to avoid any confusion. Purple Cap vials require diluent while Gray Cap vials do not.
Moderna 14-dose vials have expired, and there is no more product available for ordering. Please check inventory expiration dates regularly and properly dispose of expired vaccine.
Expiration Date Confirmation
DHS Hosting Shared Learning Forums on Advancing Health Equity
The DHS COVID-19 Response and Recovery Team is hosting Friday forums on advancing health equity during the COVID-19 pandemic. The sessions are held on Fridays from noon to 1 p.m. and are open to anyone across Wisconsin. They will feature a community leader sharing experiences, barriers, practices and lessons learned for advancing health equity.
Our forums spotlight the work being done to advance health equity in marginalized populations. Attend all the sessions or choose the ones that work best for you:
-
Friday, May 27, 12-1pm: Southeast Asian
-
Friday, June 3, 12-1pm: Middle East Communities
-
Friday, June 10, 12-1pm: Pacific Islander Communities
-
Friday, June 17, 12-1pm: Youth Populations
-
Friday, June 24, 12-1pm: Open Forum
For registration, please go to:
If you have previously registered in April, you do not need to register again. To view recordings of previous forums, please go to:
Pfizer COVID-19 Vaccine Medical Updates and Immunization Site Training Sessions
Pfizer Vaccines US Medical Affairs continues to lead Medical Updates and Immunization Site Training Sessions for all health care providers on the proper use of the Pfizer BioNTech COVID-19 vaccine.
The Immunization Site Training is divided into two sections.
Section 1: Medical Updates and New Information for the Vaccine
-
FDA approvals, authorizations - including recent authorizations
- Extended expiry for Purple, Orange, and Gray cap
-
Booster dose authorization for individuals 5 through 11 years
-
CDC Interim Clinical Considerations - Recent Updates
-
Healthcare provider resources
-
Question and answer session
Section 2: Storage, Handling, and Administration of the Vaccine
-
Use of each vaccine presentation, including storage, handling, preparation, and administration for:
- Ages 5 through 11 Years: DILUTE BEFORE USE/Orange Cap
-
Ages 12 Years and Older: DO NOT DILUTE/Gray Cap; DILUTE BEFORE USE/Purple Cap
-
Question and answer session
To access dates and links for upcoming training sessions, please visit:
|
|
|
|
|
